An independent jury of experts will evaluate entries based on scientific merit, feasibility, and potential patient impact.

Fareva has opened a new GMP Pilot Unit at its Pau site to produce liquid and lyophilized injectable forms. With its new ...

This will support the advancement of a novel ophthalmic therapeutic through clinical development and onto the market.